Financial overview

Oncoinvent financial report data and keyfigures. History for income statement, balance sheet and cash flow.

Pre
Pre
Pre

Description

Oncoinvent ASA is a clinical-stage company focused on developing radiopharmaceutical drugs against cancer. Its product candidate Radspherin is designed for targeted local treatment of metastatic cancers in body cavities using potent alpha radiation. It is currently evaluated in a Phase 2 randomized controlled study of ovarian cancer, building on previous encouraging safety data and signals of efficacy.

Medical Equipment